16-177120-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_000558.5(HBA1):c.287C>T(p.Pro96Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P96A) has been classified as Likely benign.
Frequency
Consequence
NM_000558.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBA1 | NM_000558.5 | c.287C>T | p.Pro96Leu | missense_variant | 2/3 | ENST00000320868.9 | NP_000549.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBA1 | ENST00000320868.9 | c.287C>T | p.Pro96Leu | missense_variant | 2/3 | 1 | NM_000558.5 | ENSP00000322421.5 | ||
HBA1 | ENST00000472694.1 | n.423C>T | non_coding_transcript_exon_variant | 1/2 | 1 | |||||
HBA1 | ENST00000487791.1 | n.256C>T | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
HBA1 | ENST00000397797.1 | c.191C>T | p.Pro64Leu | missense_variant | 2/3 | 2 | ENSP00000380899.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 7.07e-7 AC: 1AN: 1414336Hom.: 0 Cov.: 28 AF XY: 0.00000142 AC XY: 1AN XY: 702278
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 20, 2024 | Variant summary: HBA1 c.287C>T (p.Pro96Leu; aka Hb Georgia) results in a non-conservative amino acid change in the encoded protein sequence. Four of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-07 in 1560800 control chromosomes in the gnomAD database (v4.1 dataset). A variant, described as c.287C>T in the alpha-globin gene (the gene, i.e. HBA1 or HBA2, was not specified), has been reported in the literature in an individual affected with hemolytic anemia, however a co-occurring (potentially pathogenic) HBB variant could explain the phenotype (Medri_2022), moreover, a family member, who carried the variant in isolation didn't show signs of hemolysis. The IthaNet database reports the variant c.287C>T in both the HBA1 and HBA2 genes as Benign / Likely Benign (IthaIDs: 3718,683). To our knowledge, no experimental evidence demonstrating an impact on HBA1 protein function has been reported; however, the c.287C>T variant in HBA2 has been reported to result in increased oxygen affinity (PMID 5012316), but no effect on mRNA synthesis (PMID 8745431). The following publication have been ascertained in the context of this evaluation (PMID: 35397565). ClinVar contains an entry for this variant (Variation ID: 15730). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jan 13, 2017 | - - |
HEMOGLOBIN G (GEORGIA) Other:1
other, no assertion criteria provided | literature only | OMIM | Jul 20, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at